Leïla Belkhir

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

Alexis Wérion, Leïla Belkhir, Marie Perrot et al. · Kidney International · 2020 · 231 citations · Full text

Glomerulonephritis, Urology, Renal Function +10

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

Antoine Guilmot, Sofia Maldonado Slootjes, Amina Sellimi et al. · Journal of Neurology · 2020 · 197 citations · Full text

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 150 citations · Full text

Translational Medicine, Antifungal Agent, Antifungal Agents +6

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

Lucy Catteau, Nicolás Dauby, Marion Montourcy et al. · International Journal of Antimicrobial Agents · 2020 · 125 citations · Full text

Nationwide Observational Study, Covid-19 Pandemic, Infection Control +9